DJIA 17,063.51 -16.06 -0.09%
NASDAQ 4,571.43 13.73 0.30%
S&P 500 1,999.24 2.50 0.13%
market minute promo


161.90 2.06 (1.29%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

XBI $161.90 1.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $160.06
Previous Close $159.84
Daily Range $160.02 - $161.67
52-Week Range $113.22 - $172.52
Market Cap $1.2B
Dividend (Yield) $2.46 (0.7%)
Volume 49,890
Average Daily Volume 337,361

News & Commentary

1 of These 3 Cratering Biotechs Is a Buy

Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.

After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary

Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary

Tuesday's ETF Movers: XBI, XLU

Biotech Stock Boom Times Are Back

Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY

ETF Outlook: SPDR S and P Biotech ETF (XBI)

Tuesday's ETF Movers: XBI, XOP

Thursday's ETF Movers: BSCF, XBI

Friday's ETF Movers: GDXJ, XBI

Forecast Part II: Sell S&P 500 Passive Interests - This Market Is For Stock Pickers

See More XBI News...


Sector Equity


Health/Biotechnology Funds

SPDR S&P Biotech (ETF) (XBI) Description

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index. Website: